Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Are U.S. trends a barometer of future cancer transitions in emerging economies?

Vaccarella S, Bray F.

Int J Cancer. 2019 Jun 4. doi: 10.1002/ijc.32485. [Epub ahead of print]

PMID:
31162837
2.

Thyroid cancer in Friuli Venezia Giulia, northeastern Italy: incidence, overdiagnosis, and impact of type of surgery on survival.

Panato C, Serraino D, De Santis E, Forgiarini O, Angelin T, Bidoli E, Zanier L, Del Zotto S, Vaccarella S, Franceschi S, Dal Maso L.

Tumori. 2019 Mar 28:300891619839307. doi: 10.1177/0300891619839307. [Epub ahead of print]

PMID:
30917766
3.

Long-term strategies for thyroid health monitoring after nuclear accidents: recommendations from an Expert Group convened by IARC.

Togawa K, Ahn HS, Auvinen A, Bauer AJ, Brito JP, Davies L, Kesminiene A, Laurier D, Ostroumova E, Pacini F, Reiners C, Shinkarev S, Thomas G, Tronko M, Vaccarella S, Schüz J.

Lancet Oncol. 2018 Oct;19(10):1280-1283. doi: 10.1016/S1470-2045(18)30680-6. Epub 2018 Oct 1. No abstract available.

PMID:
30303113
4.

Thyroid cancer "epidemic" also occurs in low- and middle-income countries.

Lortet-Tieulent J, Franceschi S, Dal Maso L, Vaccarella S.

Int J Cancer. 2019 May 1;144(9):2082-2087. doi: 10.1002/ijc.31884. Epub 2018 Nov 5.

5.

Hepatitis B Virus Blocks the CRE/CREB Complex and Prevents TLR9 Transcription and Function in Human B Cells.

Tout I, Gomes M, Ainouze M, Marotel M, Pecoul T, Durantel D, Vaccarella S, Dubois B, Loustaud-Ratti V, Walzer T, Alain S, Chemin I, Hasan U.

J Immunol. 2018 Oct 15;201(8):2331-2344. doi: 10.4049/jimmunol.1701726. Epub 2018 Sep 5.

PMID:
30185518
6.

Reducing Social Inequalities in Cancer: Setting Priorities for Research.

Vaccarella S, Lortet-Tieulent J, Saracci R, Fidler MM, Conway DI, Vilahur N, Sarfati D, Jemal A, Mackenbach JP, Marmot MG, Straif K, Wild CP.

CA Cancer J Clin. 2018 Sep;68(5):324-326. doi: 10.3322/caac.21463. Epub 2018 Jul 10. No abstract available.

7.

The impact of overdiagnosis on thyroid cancer epidemic in Italy,1998-2012.

Dal Maso L, Panato C, Franceschi S, Serraino D, Buzzoni C, Busco S, Ferretti S, Torrisi A, Falcini F, Zorzi M, Cirilli C, Mazzucco W, Magoni M, Collarile P, Pannozzo F, Caiazzo AL, Russo AG, Gili A, Caldarella A, Zanetti R, Michiara M, Mangone L, Filiberti RA, Fusco M, Gasparini F, Tagliabue G, Cesaraccio R, Tumino R, Gatti L, Tisano F, Piffer S, Sini GM, Mazzoleni G, Rosso S, Fanetti AC, Vaccarella S; for AIRTUM working group.

Eur J Cancer. 2018 May;94:6-15. doi: 10.1016/j.ejca.2018.01.083. Epub 2018 Mar 20.

PMID:
29502036
8.

Cervical cancer in Africa, Latin America and the Caribbean and Asia: Regional inequalities and changing trends.

Vaccarella S, Laversanne M, Ferlay J, Bray F.

Int J Cancer. 2017 Nov 15;141(10):1997-2001. doi: 10.1002/ijc.30901. Epub 2017 Aug 10.

9.

Correction: Immuno-related polymorphisms and cervical cancer risk: The IARC multicentric case-control study.

McKay J, Tenet V, Franceschi S, Chabrier A, Gheit T, Gaborieau V, McKay-Chopin S, Avogbe PH, Tommasino M, Ainouze M, Hasan U, Vaccarella S.

PLoS One. 2017 Jul 7;12(7):e0181285. doi: 10.1371/journal.pone.0181285. eCollection 2017.

10.

Immuno-related polymorphisms and cervical cancer risk: The IARC multicentric case-control study.

McKay J, Tenet V, Franceschi S, Chabrier A, Gheit T, Gaborieau V, Chopin S, Avogbe PH, Tommasino M, Ainouze M, Hasan U, Vaccarella S.

PLoS One. 2017 May 15;12(5):e0177775. doi: 10.1371/journal.pone.0177775. eCollection 2017. Erratum in: PLoS One. 2017 Jul 7;12 (7):e0181285.

11.

Assessing global transitions in human development and colorectal cancer incidence.

Fidler MM, Bray F, Vaccarella S, Soerjomataram I.

Int J Cancer. 2017 Jun 15;140(12):2709-2715. doi: 10.1002/ijc.30686. Epub 2017 Mar 24.

12.

Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study.

Vaccarella S, Franceschi S, Zaridze D, Poljak M, Veerus P, Plummer M, Bray F.

Lancet Oncol. 2016 Oct;17(10):1445-1452. doi: 10.1016/S1470-2045(16)30275-3. Epub 2016 Aug 23.

13.

Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.

Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L.

N Engl J Med. 2016 Aug 18;375(7):614-7. doi: 10.1056/NEJMp1604412. No abstract available.

PMID:
27532827
14.

Comparison of Two Widely Used Human Papillomavirus Detection and Genotyping Methods, GP5+/6+-Based PCR Followed by Reverse Line Blot Hybridization and Multiplex Type-Specific E7-Based PCR.

Clifford GM, Vaccarella S, Franceschi S, Tenet V, Umulisa MC, Tshomo U, Dondog B, Vorsters A, Tommasino M, Heideman DA, Snijders PJ, Gheit T.

J Clin Microbiol. 2016 Aug;54(8):2031-8. doi: 10.1128/JCM.00618-16. Epub 2016 May 25.

15.

Beral's 1974 paper: A step towards universal prevention of cervical cancer.

Franceschi S, Vaccarella S.

Cancer Epidemiol. 2015 Dec;39(6):1152-6. doi: 10.1016/j.canep.2015.10.019. Epub 2015 Oct 26. Review.

PMID:
26514971
16.

The incremental benefits of implementing effective cervical cancer screening.

Vaccarella S, Franceschi S, Bray F.

Int J Cancer. 2016 Jan 1;138(1):254-5. doi: 10.1002/ijc.29700. Epub 2015 Aug 13. No abstract available.

17.

The Impact of Diagnostic Changes on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Selected High-Resource Countries.

Vaccarella S, Dal Maso L, Laversanne M, Bray F, Plummer M, Franceschi S.

Thyroid. 2015 Oct;25(10):1127-36. doi: 10.1089/thy.2015.0116. Epub 2015 Aug 20.

PMID:
26133012
18.

Thyroid cancer: an epidemic of disease or an epidemic of diagnosis?

Franceschi S, Vaccarella S.

Int J Cancer. 2015 Jun 1;136(11):2738-9. doi: 10.1002/ijc.29311. Epub 2014 Nov 12. No abstract available.

19.

50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence.

Vaccarella S, Franceschi S, Engholm G, Lönnberg S, Khan S, Bray F.

Br J Cancer. 2014 Aug 26;111(5):965-9. doi: 10.1038/bjc.2014.362. Epub 2014 Jul 3.

20.

Clustering patterns of human papillomavirus infections among HIV-positive women in Kenya.

Vaccarella S, De Vuyst H, Mugo NR, Sakr SR, Plummer M, Heideman DA, Franceschi S, Chung M.

Infect Agent Cancer. 2013 Dec 19;8(1):50. doi: 10.1186/1750-9378-8-50.

21.

Extended Middle East and North Africa: summary recommendations for the prevention of human papillomavirus infections and related cancers including cervical cancer.

Seoud M, Vaccarella S, El-Kak F, Sancho-Garnier H, Jumaan AO, Kim JJ, Garland SM, Stern PL, LaMontagne DS, Albero G, Bosch FX.

Vaccine. 2013 Dec 30;31 Suppl 6:G78-9. doi: 10.1016/j.vaccine.2012.11.078. No abstract available.

PMID:
24331823
22.

Burden of human papillomavirus infections and related diseases in the extended Middle East and North Africa region.

Vaccarella S, Bruni L, Seoud M.

Vaccine. 2013 Dec 30;31 Suppl 6:G32-44. doi: 10.1016/j.vaccine.2012.06.098. Review.

PMID:
24331818
23.

Patterns of human papillomavirus types in multiple infections: an analysis in women and men of the high throughput human papillomavirus monitoring study.

Vaccarella S, Söderlund-Strand A, Franceschi S, Plummer M, Dillner J.

PLoS One. 2013 Aug 19;8(8):e71617. doi: 10.1371/journal.pone.0071617. eCollection 2013.

24.

Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors.

Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F.

Eur J Cancer. 2013 Oct;49(15):3262-73. doi: 10.1016/j.ejca.2013.04.024. Epub 2013 Jun 8.

PMID:
23751569
25.

Prevalence of human papillomavirus types in cervical lesions from women in rural Western India.

Deodhar K, Gheit T, Vaccarella S, Romao CC, Tenet V, Nene BM, Jayant K, Kelkar R, Malvi SG, Sylla BS, Franceschi S, Jeronimo J, Shastri S, Sankaranarayanan R, Tommasino M.

J Med Virol. 2012 Jul;84(7):1054-60. doi: 10.1002/jmv.23310.

PMID:
22585722
26.

Dried blood spot samples for seroepidemiology of infections with human papillomaviruses, Helicobacter pylori, Hepatitis C Virus, and JC Virus.

Waterboer T, Dondog B, Michael KM, Michel A, Schmitt M, Vaccarella S, Franceschi S, Clifford G, Pawlita M.

Cancer Epidemiol Biomarkers Prev. 2012 Feb;21(2):287-93. doi: 10.1158/1055-9965.EPI-11-1001. Epub 2011 Dec 6.

27.

Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study.

Carozzi F, Ronco G, Gillio-Tos A, De Marco L, Del Mistro A, Girlando S, Franceschi S, Plummer M, Vaccarella S; New Technologies for Cervical Cancer screening (NTCC) Working Group.

Eur J Cancer. 2012 Jul;48(11):1633-7. doi: 10.1016/j.ejca.2011.10.010. Epub 2011 Nov 14.

PMID:
22088483
28.

Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies.

Castellsagué X, Díaz M, Vaccarella S, de Sanjosé S, Muñoz N, Herrero R, Franceschi S, Meijer CJ, Bosch FX.

Lancet Oncol. 2011 Oct;12(11):1023-31. doi: 10.1016/S1470-2045(11)70223-6. Epub 2011 Sep 12.

PMID:
21917519
29.

Clustering of human papillomavirus (HPV) types in the male genital tract: the HPV in men (HIM) study.

Vaccarella S, Plummer M, Franceschi S, Gravitt P, Papenfuss M, Smith D, Villa L, Ponce EL, Giuliano AR.

J Infect Dis. 2011 Nov 15;204(10):1500-4. doi: 10.1093/infdis/jir595. Epub 2011 Sep 9.

30.

Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica.

Vaccarella S, Franceschi S, Herrero R, Schiffman M, Rodriguez AC, Hildesheim A, Burk RD, Plummer M.

J Infect Dis. 2011 Aug 1;204(3):385-90. doi: 10.1093/infdis/jir286.

31.

Protein S-100B as biochemical marker of brain ischemic damage after treatment of carotid stenosis.

Scarcello E, Morrone F, Piro P, Tarsitano S, Intrieri F, Vaccarella S, Guerra E, Serra R, de Franciscis S.

Ann Vasc Surg. 2011 Oct;25(7):975-8. doi: 10.1016/j.avsg.2011.03.007. Epub 2011 May 28.

PMID:
21620650
32.

Multiple human papillomavirus infections: the exception or the rule?

Plummer M, Vaccarella S, Franceschi S.

J Infect Dis. 2011 Apr 1;203(7):891-3. doi: 10.1093/infdis/jiq146. No abstract available.

PMID:
21402540
33.

Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia.

Alibegashvili T, Clifford GM, Vaccarella S, Baidoshvili A, Gogiashvili L, Tsagareli Z, Kureli I, Snijders PJ, Heideman DA, van Kemenade FJ, Meijer CJ, Kordzaia D, Franceschi S.

Cancer Epidemiol. 2011 Oct;35(5):465-70. doi: 10.1016/j.canep.2010.12.006. Epub 2011 Feb 2.

PMID:
21292583
34.

Author's reply to: Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.

Vaccarella S, Clifford GM, Howell-Jones R, Snijders PJ, Franceschi S; International Agency for Research on Cancer Multicentric Cervical Cancer Study Group.

Int J Cancer. 2011 Sep 1;129(5):1283-5. doi: 10.1002/ijc.25774. Epub 2011 Feb 11. No abstract available.

35.

The prevalence of human papillomavirus infection in Mombasa, Kenya.

De Vuyst H, Parisi MR, Karani A, Mandaliya K, Muchiri L, Vaccarella S, Temmerman M, Franceschi S, Lillo F.

Cancer Causes Control. 2010 Dec;21(12):2309-13. doi: 10.1007/s10552-010-9645-z. Epub 2010 Oct 12.

PMID:
20938733
36.

Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys.

Vaccarella S, Franceschi S, Clifford GM, Touzé A, Hsu CC, de Sanjosé S, Pham TH, Nguyen TH, Matos E, Shin HR, Sukvirach S, Thomas JO, Boursaghin L, Gaitan J, Snijders PJ, Meijer CJ, Muñoz N, Herrero R, Coursaget P; IARC HPV Prevalence Surveys Study Group.

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2379-88. doi: 10.1158/1055-9965.EPI-10-0336.

37.

Human papillomavirus infection in women with and without cervical cancer in Nepal.

Sherpa AT, Clifford GM, Vaccarella S, Shrestha S, Nygård M, Karki BS, Snijders PJ, Meijer CJ, Franceschi S.

Cancer Causes Control. 2010 Mar;21(3):323-30. doi: 10.1007/s10552-009-9467-z. Epub 2009 Nov 22.

PMID:
20217467
38.

Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys.

Vaccarella S, Franceschi S, Snijders PJ, Herrero R, Meijer CJ, Plummer M; IARC HPV Prevalence Surveys Study Group.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):503-10. doi: 10.1158/1055-9965.EPI-09-0983.

39.

Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium.

Heck JE, Berthiller J, Vaccarella S, Winn DM, Smith EM, Shan'gina O, Schwartz SM, Purdue MP, Pilarska A, Eluf-Neto J, Menezes A, McClean MD, Matos E, Koifman S, Kelsey KT, Herrero R, Hayes RB, Franceschi S, Wünsch-Filho V, Fernández L, Daudt AW, Curado MP, Chen C, Castellsagué X, Ferro G, Brennan P, Boffetta P, Hashibe M.

Int J Epidemiol. 2010 Feb;39(1):166-81. doi: 10.1093/ije/dyp350. Epub 2009 Dec 18.

40.

Differences in the risk of cervical cancer and human papillomavirus infection by education level.

Franceschi S, Plummer M, Clifford G, de Sanjose S, Bosch X, Herrero R, Muñoz N, Vaccarella S; International Agency for Research on Cancer Multicentric Cervical Cancer Study Groups; International Agency for Research on Cancer Human Papillomavirus Prevalence Surveys Study Group.

Br J Cancer. 2009 Sep 1;101(5):865-70. doi: 10.1038/sj.bjc.6605224. Epub 2009 Aug 4.

41.

Sexual activity and hepatitis B and C virus infection among young adults after introduction of a vaccination program in an area of high endemicity.

Lim MK, Franceschi S, Vaccarella S, Ju YH, Oh JK, Kong HJ, Kim DI, Kim BG, Kim JI, Jung KY, Lee DS, Shin HR.

J Epidemiol. 2009;19(5):213-8. Epub 2009 Aug 1.

42.

Herpes simplex virus type-2 seropositivity among ever married women in South and north Vietnam: a population-based study.

Le HV, Schoenbach VJ, Herrero R, Hoang Pham AT, Nguyen HT, Nguyen TT, Muñoz N, Franceschi S, Vaccarella S, Parkin MD, Snijders PJ, Morrow RA, Smith JS.

Sex Transm Dis. 2009 Oct;36(10):616-20. doi: 10.1097/OLQ.0b013e3181a8cde4.

43.

Age as a predictive factor in glioblastomas: population-based study.

Kita D, Ciernik IF, Vaccarella S, Franceschi S, Kleihues P, Lütolf UM, Ohgaki H.

Neuroepidemiology. 2009;33(1):17-22. doi: 10.1159/000210017. Epub 2009 Mar 27.

44.

Prevalence of human papillomavirus types in cervical and oral cancers in central India.

Gheit T, Vaccarella S, Schmitt M, Pawlita M, Franceschi S, Sankaranarayanan R, Sylla BS, Tommasino M, Gangane N.

Vaccine. 2009 Jan 29;27(5):636-9. doi: 10.1016/j.vaccine.2008.11.041. Epub 2008 Dec 3.

PMID:
19056450
45.

Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study.

Zawlik I, Vaccarella S, Kita D, Mittelbronn M, Franceschi S, Ohgaki H.

Neuroepidemiology. 2009;32(1):21-9. doi: 10.1159/000170088. Epub 2008 Nov 8.

PMID:
18997474
46.

Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.

Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, Enkhtuya S, Kommoss F, Wentzensen N, Snijders PJ, Meijer CJ, Franceschi S, Pawlita M.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1731-8. doi: 10.1158/1055-9965.EPI-07-2796.

47.

Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas.

Zawlik I, Kita D, Vaccarella S, Mittelbronn M, Franceschi S, Ohgaki H.

Brain Pathol. 2009 Apr;19(2):188-94. doi: 10.1111/j.1750-3639.2008.00170.x. Epub 2008 May 6.

PMID:
18462472
48.

Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys.

Vaccarella S, Herrero R, Snijders PJ, Dai M, Thomas JO, Hieu NT, Ferreccio C, Matos E, Posso H, de Sanjosé S, Shin HR, Sukvirach S, Lazcano-Ponce E, Muñoz N, Meijer CJ, Franceschi S; IARC HPV Prevalence Surveys (IHPS) Study Group.

Int J Epidemiol. 2008 Jun;37(3):536-46. doi: 10.1093/ije/dyn033. Epub 2008 Mar 3.

PMID:
18316350
49.

Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland.

Bardin A, Vaccarella S, Clifford GM, Lissowska J, Rekosz M, Bobkiewicz P, Kupryjańczyk J, Krynicki R, Jonska-Gmyrek J, Danska-Bidzinska A, Snijders PJ, Meijer CJ, Zatonski W, Franceschi S.

Eur J Cancer. 2008 Mar;44(4):557-64. doi: 10.1016/j.ejca.2007.12.001. Epub 2008 Jan 11.

PMID:
18191395
50.

Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea.

Clifford GM, Shin HR, Oh JK, Waterboer T, Ju YH, Vaccarella S, Quint W, Pawlita M, Franceschi S.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1874-9.

Supplemental Content

Loading ...
Support Center